home / stock / vtrs / vtrs news


VTRS News and Press, Viatris Inc. From 05/22/23

Stock Information

Company Name: Viatris Inc.
Stock Symbol: VTRS
Market: NASDAQ
Website: viatris.com

Menu

VTRS VTRS Quote VTRS Short VTRS News VTRS Articles VTRS Message Board
Get VTRS Alerts

News, Short Squeeze, Breakout and More Instantly...

VTRS - Viatris Announces Appointment of Leo Groothuis to Company's Board of Directors

Viatris Announces Appointment of Leo Groothuis to Company's Board of Directors PR Newswire PITTSBURGH , May 22, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing board refreshment effort...

VTRS - Viatris Shareholder Notice

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Viatris To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 21, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inv...

VTRS - Viatris Shareholder Action Reminder

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Viatris To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 19, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inv...

VTRS - It's Cheap and Pays a Big Dividend, But Is Viatris Stock a Buy?

2023-05-18 06:28:00 ET Companies that produce generic drugs aren't known for being exciting investments, and there's little chance they'll ever expand as fast as your average tech stock or most other growth stocks. If they can manage to be a safer holding than faster-growing stocks, though,...

VTRS - Viatris Deadline Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Viatris To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 17, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inv...

VTRS - Viatris to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

Viatris to Participate in Goldman Sachs 44th Annual Global Healthcare Conference PR Newswire PITTSBURGH , May 17, 2023 /PRNewswire/ -- Viatris Inc. ( NASDAQ : VTRS ), a global healthcare company, today announced the company will participate in the ...

VTRS - Viatris Publishes Sustainability Report Showcasing 2022 Progress on Building Sustainable Access to Medicine

Viatris Publishes Sustainability Report Showcasing 2022 Progress on Building Sustainable Access to Medicine PR Newswire Supplied medicines to approximately 1 billion patients globally PITTSBURGH , May 16, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTR...

VTRS - Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2023 Update

2023-05-09 20:42:32 ET Summary Davis Selected Advisers 13F portfolio value increased from $14.71B to $15.13B this quarter. They increased Amazon and JD.com while reducing Quest Diagnostics. The top three positions are Meta Platforms, Berkshire Hathaway, and Wells Fargo, and th...

VTRS - Viatris Inc. (VTRS) Q1 2023 Earnings Call Transcript

2023-05-08 12:37:03 ET Viatris Inc. (VTRS) Q1 2023 Results Conference Call May 08, 2023 08:30 AM ET Company Participants Bill Szablewski - Head of Capital Markets Scott Smith - Incoming Chief Executive Officer Rajiv Malik - President Sanjeev Narula - Chief Fi...

VTRS - Viatris: That Free Cash Flow Is Not As Attractive As It Sounds

2023-05-08 10:57:48 ET Summary Viatris has struggled to gain ground over the last year. This has happened despite management stressing the free cash flow generation ability of the business. Q1-2023 results showed just how much work management needs to do to make this a comebac...

Previous 10 Next 10